West Midlands Genomic Medicine Centre have published an article about their success with the TissueSAFE in the 100K genome project which will soon become the National Genomic Medicine Service. They are using the TissueSAFE Plus to vacuum seal their specimens reducing the use of formalin.
Read more: Heartlands Hospital Going Formalin Free for 100K Specimens
Ready more to find out what upcoming events we are attending.
Read more to find out what events we've recently attended.
October is Breast Cancer awareness month. Menarini Diagnostics are proud to offer key breast antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
Read more: Key antibodies for the identification of Breast Cancer
We organised the first two in a series of Innovations in Cellular Pathology Symposiums on 12th and 13th June in London and Manchester. The symposiums attracted a good amount of attendees mainly from histopathology departments both in London and Manchester. This years agenda focused on patient centred processing solutions, standardisation and achieving a lean laboratory workflow.
12th-18th June is Cervical Cancer screening awareness week. Menarini Diagnostics are proud to offer key cervical antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
Read more: Key Antibodies for Identification of Cervical Cancer Proteins
Menarini Diagnostics are pleased to invite you to a webinar on Thursday 28th June.
The webinar will provide a comprehensive description on how to digitally document the delicate step of tissue specimen dissection.
Read more: Webinar about digital documentation of the specimen dissection on 28th June
6th-8th June the Fondazione Internazionale Menarini hosted the congress "Innovation in Transplantation: The Digital Era" in Verona. This two day congress with high level speakers from Europe attracted over 170 key opinion leaders from the transplantation and digital pathology society. We had 10 attendees from UK attending the event. One of the highlights of the congress was Dr Desley Neil's presentation about the kidney quality assessment and its limits.
May is Skin Cancer awareness month. Menarini Diagnostics are proud to offer key dermatopathology antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
Read more: Key Antibodies for Identification of Melanoma Proteins
Menarini Diagnostics are pleased to invite you to attend a webinar about formalin free surgical specimen handling from operating theatres to histopathology laboratories on the 10th May.
The webinar will provide a comprehensive description on the validation procedure, which allows samples to be transported from operating theatres to pathology laboratories in safer and more economical manner.
Read more: Webinar about formalin free handling of surgical specimens from operating theatres to...
April 9th-15th is Orchid Male Cancer awareness week. Menarini Diagnostics are proud to offer key prostate antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
Read more: Key Antibodies for Identification of Prostate Cancer Proteins
April is Bowel Cancer awareness month. Menarini Diagnostics are proud to offer key bowel antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
Read more: Key Antibodies for Identification of Bowel Cancer Proteins
March is Ovarian Cancer awareness month. Menarini Diagnostics are proud to offer key ovarian antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
Read more: Key Antibodies for Identification of Ovarian Cancer Proteins
Have you heard about Synergy? It’s a revolutionary patented method to embed tissues on-board your tissue processor, as part of the processing protocols. Menarini’s Pathos Delta and Logos Hybrid Tissue Processors can both be used with the dedicated Synergy rack and consumables to achieve on-board embedding. A variety of tissue types and dimensions can be processed and embedded with this method.
Read more: On-Board Embedding Now Available on Your Tissue Processor Patient Centred Processing TM
Menarini Diagnostics recently attended the Association of Anatomical Pathology Technology conference in Cardiff. The annual AAPT conference is an opportunity for delegates to update their knowledge of scientific, technological, legal and social issues relating to the healthcare science profession of anatomical pathology technology. The AAPT conference was attended mostly by mortuary technicians and presentations covered for instance diseases in the mortuary, inspection preparation and organ donation. On the Total Tissue Diagnostics exhibition stand there was the opportunity to see the Gold standard for digital imaging, the MacroVIEW DM that gathered a large of amount of interest. We would like to thank everyone that joined us at the meeting and we look forward to seeing you again.
The report from England's chief medical officer Professor Dame Sally Davies details the ambition of NHS England to routinely provide genetic testing for cancer patients within the next five years. Professor Sally Davies wants whole genome sequencing to become as standard as blood tests and biopsies. In about two-thirds of cases, this type of information can improve the diagnosis and allows doctors to tailor treatment to the individual, ensuring patients receive the most effective drugs. At the moment more than 31,000 NHS patients have had their entire genetic code sequenced since 2013. At present there are 25 regional laboratories performing this type of genetic testing.
Patient Centred Processing is a new approach from Menarini to ensure that all patient samples are handled safely and quickly, to increase laboratory throughput and provide an accurate and fast turnaround time of results to patients.
There is a ‘national ambition in England to achieve earlier diagnosis’ as indicated in a report of the Independent Cancer Taskforce. The recommendation is that 95% of patients referred for testing by a GP should receive their results within 4 weeks by 2020.
Menarini Diagnostics has organised the second Surgical Specimen Symposium seminar in 2017. The event was held at the Renaissance Manchester Hotel on Wednesday 28th June. There where ones again around 20-30 attendees from different departments and institutions such as laboratories, tissue banks, operating theatres and Health & Safety.
Read more: Menarini's Seminar Series: Surgical Specimen Management® Event 28th of June
Category 1B substances are presumed to have carcinogenic potential for humans. Therefore under COSHH there is a duty on employers to reduce exposure to such substances to as low a level as is reasonably practicable.
